Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omegaven in Cardiac Surgery and Myocardial Infarction
NCT00516178Phase 3Completed
- Sponsor
- Lausanne University Hospital
- Start
- Jan 2008
- Primary completion
- Mar 2011
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of eicosapentaenoic acid + docosahexaenoic acid in coronary artery disease (CAD), myocardial infarction (MI), sponsored by Lausanne University Hospital. Started Jan 2008; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
coronary artery disease (CAD)myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00516178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00516178.